// App-Quantinova.ai

158 : Multiplexed protein and gene profiling of circulating tumor cells (CTCs) in metastatic castration-resistant prostate cancer (mCRPC) using automated immunofluorescence and fluorescence in situ hybridization.

Researchers

Presenter

  • Dea Nagy

Principal Investigators

  • Eric Tucker

  • Samatha Rajkovich

  • Ryan Dittamore

  • Steven French

  • Karl Garsha

  • Steve Yun

  • Katherine Smith

  • Karim Sallam

  • Elias Liabotis

  • Michael Otter

  • Dena Marrinucci

Medical Centers

  • Epic Sciences, Inc., La Jolla, CA

  • Ventana Medical Systems, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Circulating tumor cells

  • ETS transcription factor ERG

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved